CLX
CLOROX CO /DE/
NYSE · Consumer Defensive · Household & Personal Products · US
$85.56
−1.76%Year over year
Reported trailing growth
- Revenue
- -5.4%
- EBITDA
- -16.0%
- EBIT
- +40.1%
- EPS
- -26.6%
- Free cash flow
- -46.8%
- Operating cash flow
- -37.6%
Forward estimates
Based on analyst estimates
- Revenue
- +14.2%
- EBITDA
- +23.3%
- EPS
- +21.5%
Three-year CAGR
- Revenue
- -3.1%
- EBITDA
- +27.5%
- EBIT
- +26.4%
- Net income
- +57.9%
- EPS
- +58.5%
- Free cash flow
- -24.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026